Dispersin B, Antibiofilm Peptides & Biofilm Disruption Strategies
A focused research library on Dispersin B and antibiofilm peptide strategies — covering biofilm formation mechanisms, enzymatic disruption via Dispersin B (DspB), lab protocols for biofilm quantification, and the emerging role of antimicrobial peptides in biofilm eradication research.
Lead Compound
Dispersin B (DspB)
Primary Research Area
Biofilm Disruption
Key Mechanism
Poly-β-1,6-GlcNAc hydrolysis
Research Articles
4+ peer-reviewed overviews
Dispersin B is a glycoside hydrolase enzyme studied for its ability to degrade poly-N-acetylglucosamine (PNAG) biofilms, with research applications in chronic infection models, medical device contamination, and combination antimicrobial strategies.
A practical laboratory reference for researchers working with Dispersin B, covering enzyme storage, activity assays, biofilm disruption protocols, and combination antimicrobial study design.
A comprehensive overview of standard biofilm research methods used in preclinical studies, including in vitro assays, flow cell models, animal infection models, and key analytical techniques.
An overview of peptide-based strategies for studying and disrupting bacterial biofilms in research models, including enzymatic approaches (Dispersin B), antimicrobial peptides (AMPs), and combination protocols.
An in-depth review of LL-37, the only human cathelicidin, covering its antimicrobial mechanisms, immunomodulatory functions, wound healing properties, and emerging research applications in infection, inflammation, and cancer models.
FOR RESEARCH PURPOSES ONLY — All content in this hub is intended strictly for scientific and educational reference. These compounds are not approved for human or animal consumption. Pure Pharm Peptides sells exclusively to qualified researchers.